The programmable nuclease can replace restriction enzymes, enables cloning of large genomic sequences, and can deplete unwanted DNA species.
Heat-Seq, scheduled to launch in the second quarter, uses empirically tested molecular inversion probes.
A team of scientists believe that exosomal miRNAs holds promise to be significant biomarkers for Alzheimer's disease.
Three individuals in a 17th century burial carried genetic signatures associated with Bantu- and non-Bantu speaking populations in parts of Cameroon, Nigeria, and Ghana.
Illumina's Nextera kits and NGS technology will be used in the the National Lung Matrix Trial being run by Cancer Research UK.
Agilent Technologies said today that it has acquired Halo Genomics, a privately held Uppsala, Sweden-based provider of sample prep tools for next-generation sequencing.
By Ben Butkus
By a GenomeWeb staff reporter
Boreal's prototype platform can differentiate and enrich for sequences that differ by one nucleotide from as many as 10,000 copies of background DNA. The company believes it has potential for use in clinical applications.
Ambry is Roche NimbleGen's first service provider in the US offering the SeqCap EZ Human Exome product.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.